Concepedia

Author

Barbro Larsson

Affibody (Sweden)

Also Known As

B. S. Larsson, Barbro Larsson

17

Publications

1K

Citations

8

H-Index

19

Concepts

All Affiliations

Affibody (Sweden)KTH Royal Institute of TechnologyKarolinska InstitutetUppsala UniversityUppsala University Hospital
BL

About

Barbro Larsson is an author at Affibody (Sweden) specializing in medicine, engineering, and tissue engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

60

2

Engineering

1

1

175

3

Natural Sciences

1

1

49

4

Biomedical Engineering

1

1

175

5

Cell Biology

1

1

49

Barbro Larsson

×

8

Publications

997

Citations

8

H-Index

YearCitations

Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule

Anna Orlova, Mikaela Magnusson, Tove Eriksson,

Cancer Research

2006

555

Design of an Optimized Scaffold for Affibody Molecules

Joachim Feldwisch, Vladimir Tolmachev, Christofer Lendel,

Journal of Molecular Biology

2010

175

Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis

Linda Johansson, Natalia Sherina, Nastya Kharlamova,

Arthritis Research & Therapy

2016

98

Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody

Eskender Mume, Anna Orlova, Barbro Larsson,

Bioconjugate Chemistry

2005

55

Site-specifically conjugated anti-HER2 Affibody® molecules as one-step reagents for target expression analyses on cells and xenograft samples

Emma Lundberg, Ingmarie Höidén‐Guthenberg, Barbro Larsson,

Journal of Immunological Methods

2006

49

Selection of affibody molecules to the ligand‐binding site of the insulin‐like growth factor‐1 receptor

Emma Lundberg, Erik Vernet, Barbro Larsson,

Biotechnology and Applied Biochemistry

2010

41

Polymerase Chain Reaction with Double Primer Pairs for Detection of Human Parvovirus B19 Induced Aplastic Crises in Family Outbreaks

Eva Fridell, Albert N. Békássy, Barbro Larsson,

Scandinavian Journal of Infectious Diseases

1992

13

Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon ? and tumour necrosis factor ? treatment of tumour cells potentiates their interaction with autologous blood lymphocytes

Farkas V�nky, Christina Hising, Kerstin Sj�wall,

Cancer Immunology Immunotherapy

1995

11

Page 1